Infinity Delta Family patient monitors The Infinity Delta Series (Delta/Delta XL/Kappa) monito...
FDA Device Recall #Z-0974-2019 — Class II — February 8, 2019
Recall Summary
| Recall Number | Z-0974-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 8, 2019 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Draegar Medical Systems, Inc. |
| Location | Andover, MA |
| Product Type | Devices |
| Quantity | 10699 in total |
Product Description
Infinity Delta Family patient monitors The Infinity Delta Series (Delta/Delta XL/Kappa) monitors are intended to be used on adult, pediatric, and neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcp02, which for the neonatal population, is to only be used when the patient is not under gas anesthesia.-Omega and Omega S are intended to be used on adult, pediatric, and neonatal populations.
Reason for Recall
The firm is recalling their Delta family of patient monitors software due to cybersecurity vulnerabilities, which may cause the device to reboot, lose functionality, and/or lose communication.
Distribution Pattern
US Nationwide distribution including Puerto Rico.
Lot / Code Information
All software versions, all serial numbers.
Other Recalls from Draegar Medical Systems, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1012-2022 | Class II | Drager Infinity CentralStation Software version... | Mar 4, 2022 |
| Z-1104-2021 | Class II | Infinity Acute Care System (IACS) Monitoring So... | Dec 23, 2020 |
| Z-0372-2020 | Class II | Infinity M300 telemetry monitoring device Softw... | Oct 9, 2019 |
| Z-0258-2020 | Class II | The Infinity Acute Care System (IACS) Monitorin... | Sep 13, 2019 |
| Z-0975-2019 | Class II | Omega Systems These devices are intended to ... | Feb 8, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.